STOCK TITAN

[144] VTEX SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

VTEX filed a Form 144 notifying the market of a proposed sale of 65,489 common shares with an aggregate market value of $282,257.59. The sale is scheduled to occur on 08/11/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The filing shows these shares were originally acquired as founders shares on 10/25/2019 and reports the issuer has 103,947,244 shares outstanding, making this a disclosure of an insider sale.

The Form also lists multiple recent 10b5-1 sales by "SIGNO INV TECH CO LTD" between May and August 2025 (including sales of 100; 6,250; and several 8,173-share transactions), indicating ongoing plan-based dispositions. The filing does not provide a date for adoption of any 10b5-1 plan or a stated reason for the proposed sale.

VTEX ha depositato un Form 144 per notificare al mercato una proposta di vendita di 65.489 azioni ordinarie per un valore di mercato complessivo di $282.257,59. La vendita è prevista per il 11/08/2025 sul NYSE tramite Morgan Stanley Smith Barney LLC. Il deposito indica che queste azioni erano state inizialmente acquisite come azioni dei fondatori il 25/10/2019 e riporta che l'emittente ha 103.947.244 azioni in circolazione, configurando così una comunicazione di vendita da parte di un insider.

Il modulo elenca inoltre più vendite recenti ai sensi della regola 10b5-1 da parte di "SIGNO INV TECH CO LTD" tra maggio e agosto 2025 (incluse vendite di 100; 6.250; e diverse transazioni da 8.173 azioni), indicando l'esistenza di disposizioni pianificate in corso. Il deposito non specifica la data di adozione di alcun piano 10b5-1 né fornisce una motivazione dichiarata per la vendita proposta.

VTEX presentó un Formulario 144 para notificar al mercado una propuesta de venta de 65.489 acciones ordinarias por un valor de mercado agregado de $282.257,59. La venta está programada para el 11/08/2025 en la NYSE a través de Morgan Stanley Smith Barney LLC. La presentación indica que estas acciones fueron adquiridas originalmente como acciones de los fundadores el 25/10/2019 y señala que el emisor tiene 103.947.244 acciones en circulación, lo que constituye una divulgación de una venta por parte de un insider.

El Formulario también enumera varias ventas recientes bajo la regla 10b5-1 realizadas por "SIGNO INV TECH CO LTD" entre mayo y agosto de 2025 (incluidas ventas de 100; 6.250; y varias transacciones de 8.173 acciones), lo que indica disposiciones basadas en planes en curso. La presentación no aporta la fecha de adopción de ningún plan 10b5-1 ni explica el motivo declarado de la venta propuesta.

VTEX는 시장에 제안된 매각을 알리기 위해 Form 144를 제출하여 65,489주의 보통주를 총 $282,257.59의 시가로 매도할 예정임을 통지했습니다. 매각은 2025년 8월 11일 NYSE에서 Morgan Stanley Smith Barney LLC를 통해 이루어질 예정입니다. 제출서류에는 해당 주식이 원래 2019년 10월 25일 창립자 주식으로 취득되었고, 발행회사가 103,947,244주를 유통 중인 것으로 보고되어 내부자 매각 공시라는 점이 나타나 있습니다.

해당 Form은 또한 "SIGNO INV TECH CO LTD"가 2025년 5월부터 8월 사이에 수행한 여러 건의 10b5-1 기반 최근 매각(100주, 6,250주 및 여러 건의 8,173주 거래 포함)을 기재하고 있어 계획에 따른 처분이 진행 중임을 시사합니다. 제출서류에는 어떠한 10b5-1 계획의 채택일이나 제안된 매각의 명시적인 사유는 기재되어 있지 않습니다.

VTEX a déposé un Formulaire 144 pour informer le marché d'une proposition de vente de 65 489 actions ordinaires pour une valeur marchande totale de $282 257,59. La vente est prévue le 11/08/2025 sur le NYSE via Morgan Stanley Smith Barney LLC. Le dépôt indique que ces actions ont été initialement acquises en tant que actions de fondateurs le 25/10/2019 et signale que l'émetteur compte 103 947 244 actions en circulation, constituant ainsi une divulgation d'une vente par un initié.

Le formulaire mentionne également plusieurs ventes récentes au titre de la règle 10b5-1 effectuées par "SIGNO INV TECH CO LTD" entre mai et août 2025 (y compris des ventes de 100 ; 6 250 ; et plusieurs transactions de 8 173 actions), ce qui indique des cessions planifiées en cours. Le dépôt ne fournit pas de date d'adoption d'un plan 10b5-1 ni de motif déclaré pour la vente proposée.

VTEX hat ein Formular 144 eingereicht, um den Markt über einen geplanten Verkauf von 65.489 Stammaktien mit einem gesamten Marktwert von $282.257,59 zu informieren. Der Verkauf ist für den 11.08.2025 an der NYSE über Morgan Stanley Smith Barney LLC geplant. Aus der Einreichung geht hervor, dass diese Aktien ursprünglich am 25.10.2019 als Gründeraktien erworben wurden und dass der Emittent 103.947.244 ausstehende Aktien hat, womit es sich um die Offenlegung eines Insider-Verkaufs handelt.

Das Formular listet zudem mehrere jüngste Verkäufe gemäß 10b5-1 durch "SIGNO INV TECH CO LTD" zwischen Mai und August 2025 auf (einschließlich Verkäufen von 100; 6.250; und mehreren Transaktionen über 8.173 Aktien), was auf laufende planbasierte Veräußerungen hinweist. Die Einreichung macht keine Angabe zum Datum der Annahme eines 10b5-1-Plans und nennt keinen angegebenen Grund für den vorgeschlagenen Verkauf.

Positive
  • Clear disclosure of proposed sale: 65,489 shares and aggregate market value $282,257.59 are specified
  • Execution through major broker: Morgan Stanley Smith Barney LLC is named as the broker, indicating an institutional execution channel
  • Founders shares identified: The shares were acquired as founders shares on 10/25/2019, which is explicitly disclosed
  • Prior 10b5-1 activity listed: Multiple 10b5-1 sales between May and August 2025 are recorded, showing consistent plan-based sales activity
Negative
  • No plan adoption date provided: The filing does not state the date the 10b5-1 plan was adopted or when instructions were given
  • No stated reason for the sale: The filing does not explain the purpose of the proposed sale or use of proceeds
  • Additional shares entering the market: The proposed sale on 08/11/2025 will add 65,489 shares to public trading

Insights

TL;DR: Scheduled insider sale of 65,489 VTEX shares via major broker; prior 10b5-1 activity shows systematic disposals.

The filing is a routine disclosure under Rule 144: it notifies the market that an insider or related person intends to sell 65,489 common shares valued at $282,257.59 on 08/11/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The shares were acquired as founders shares on 10/25/2019. The record of multiple 10b5-1 transactions by SIGNO INV TECH CO LTD between May and August 2025 suggests sales are part of an established trading approach rather than an ad hoc disposition. The filing omits the plan adoption date, limiting clarity on when pre-clearance occurred.

TL;DR: Disclosure is procedurally complete but lacks plan-adoption date; prior 10b5-1 sales provide context on selling behavior.

This Form 144 documents a proposed sale of 65,489 shares and lists multiple recent 10b5-1 sales by SIGNO INV TECH CO LTD, which is relevant to governance and insider-transactions transparency. The shares were founders shares acquired on 10/25/2019, and the filing names the executing broker and exchange. The absence of an explicit plan adoption or instruction date reduces traceability of the trading plan timeline, which is useful for assessing compliance with pre-established trading policies.

VTEX ha depositato un Form 144 per notificare al mercato una proposta di vendita di 65.489 azioni ordinarie per un valore di mercato complessivo di $282.257,59. La vendita è prevista per il 11/08/2025 sul NYSE tramite Morgan Stanley Smith Barney LLC. Il deposito indica che queste azioni erano state inizialmente acquisite come azioni dei fondatori il 25/10/2019 e riporta che l'emittente ha 103.947.244 azioni in circolazione, configurando così una comunicazione di vendita da parte di un insider.

Il modulo elenca inoltre più vendite recenti ai sensi della regola 10b5-1 da parte di "SIGNO INV TECH CO LTD" tra maggio e agosto 2025 (incluse vendite di 100; 6.250; e diverse transazioni da 8.173 azioni), indicando l'esistenza di disposizioni pianificate in corso. Il deposito non specifica la data di adozione di alcun piano 10b5-1 né fornisce una motivazione dichiarata per la vendita proposta.

VTEX presentó un Formulario 144 para notificar al mercado una propuesta de venta de 65.489 acciones ordinarias por un valor de mercado agregado de $282.257,59. La venta está programada para el 11/08/2025 en la NYSE a través de Morgan Stanley Smith Barney LLC. La presentación indica que estas acciones fueron adquiridas originalmente como acciones de los fundadores el 25/10/2019 y señala que el emisor tiene 103.947.244 acciones en circulación, lo que constituye una divulgación de una venta por parte de un insider.

El Formulario también enumera varias ventas recientes bajo la regla 10b5-1 realizadas por "SIGNO INV TECH CO LTD" entre mayo y agosto de 2025 (incluidas ventas de 100; 6.250; y varias transacciones de 8.173 acciones), lo que indica disposiciones basadas en planes en curso. La presentación no aporta la fecha de adopción de ningún plan 10b5-1 ni explica el motivo declarado de la venta propuesta.

VTEX는 시장에 제안된 매각을 알리기 위해 Form 144를 제출하여 65,489주의 보통주를 총 $282,257.59의 시가로 매도할 예정임을 통지했습니다. 매각은 2025년 8월 11일 NYSE에서 Morgan Stanley Smith Barney LLC를 통해 이루어질 예정입니다. 제출서류에는 해당 주식이 원래 2019년 10월 25일 창립자 주식으로 취득되었고, 발행회사가 103,947,244주를 유통 중인 것으로 보고되어 내부자 매각 공시라는 점이 나타나 있습니다.

해당 Form은 또한 "SIGNO INV TECH CO LTD"가 2025년 5월부터 8월 사이에 수행한 여러 건의 10b5-1 기반 최근 매각(100주, 6,250주 및 여러 건의 8,173주 거래 포함)을 기재하고 있어 계획에 따른 처분이 진행 중임을 시사합니다. 제출서류에는 어떠한 10b5-1 계획의 채택일이나 제안된 매각의 명시적인 사유는 기재되어 있지 않습니다.

VTEX a déposé un Formulaire 144 pour informer le marché d'une proposition de vente de 65 489 actions ordinaires pour une valeur marchande totale de $282 257,59. La vente est prévue le 11/08/2025 sur le NYSE via Morgan Stanley Smith Barney LLC. Le dépôt indique que ces actions ont été initialement acquises en tant que actions de fondateurs le 25/10/2019 et signale que l'émetteur compte 103 947 244 actions en circulation, constituant ainsi une divulgation d'une vente par un initié.

Le formulaire mentionne également plusieurs ventes récentes au titre de la règle 10b5-1 effectuées par "SIGNO INV TECH CO LTD" entre mai et août 2025 (y compris des ventes de 100 ; 6 250 ; et plusieurs transactions de 8 173 actions), ce qui indique des cessions planifiées en cours. Le dépôt ne fournit pas de date d'adoption d'un plan 10b5-1 ni de motif déclaré pour la vente proposée.

VTEX hat ein Formular 144 eingereicht, um den Markt über einen geplanten Verkauf von 65.489 Stammaktien mit einem gesamten Marktwert von $282.257,59 zu informieren. Der Verkauf ist für den 11.08.2025 an der NYSE über Morgan Stanley Smith Barney LLC geplant. Aus der Einreichung geht hervor, dass diese Aktien ursprünglich am 25.10.2019 als Gründeraktien erworben wurden und dass der Emittent 103.947.244 ausstehende Aktien hat, womit es sich um die Offenlegung eines Insider-Verkaufs handelt.

Das Formular listet zudem mehrere jüngste Verkäufe gemäß 10b5-1 durch "SIGNO INV TECH CO LTD" zwischen Mai und August 2025 auf (einschließlich Verkäufen von 100; 6.250; und mehreren Transaktionen über 8.173 Aktien), was auf laufende planbasierte Veräußerungen hinweist. Die Einreichung macht keine Angabe zum Datum der Annahme eines 10b5-1-Plans und nennt keinen angegebenen Grund für den vorgeschlagenen Verkauf.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does VTEX's Form 144 disclose?

The filing discloses a proposed sale of 65,489 common shares valued at $282,257.59, to be sold on 08/11/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

Who acquired the shares and when were they acquired?

The shares were acquired as founders shares on 10/25/2019, as stated in the filing.

Does the filing show prior sales by the same holder?

Yes. The filing lists multiple 10b5-1 sales by SIGNO INV TECH CO LTD between May and August 2025, including transactions of 100, 6,250, and several 8,173-share sales.

Is the 10b5-1 plan adoption date provided in the filing?

No. The filing does not provide a date for the adoption of a 10b5-1 plan or the date instructions were given.

How many shares are outstanding according to the filing?

The filing reports 103,947,244 shares outstanding for the issuer.
VTEX

NYSE:VTEX

VTEX Rankings

VTEX Latest News

VTEX Latest SEC Filings

Aug 11, 2025
[144] VTEX SEC Filing

VTEX Stock Data

1.08B
136.30M
39.86%
40.88%
2.82%
Software - Application
Technology
Link
Cayman Islands
Grand Cayman